Media contributions
1Media contributions
Title Study questions Paxlovid’s COVID-19 ‘usefulness’ Degree of recognition National Media name/outlet NewsGP Media type Web Country/Territory Australia Date 11/04/24 Description Researchers say the antiviral does little to reduce symptom duration for some vaccinated patients, but still recommended its use for the vulnerable...
Professor Mark Morgan, Chair of RACGP Expert Committee – Quality Care, told newsGP it remains unclear why these trial results were not published earlier.
‘The numbers of participants and between group differences were too small to be clear if this difference occurred by chance or because of the treatment,’ he said.
‘Similarly, there was no difference in the rates of viral load rebound or symptoms rebound after completion of the course of Paxlovid.’Producer/Author Michelle Wisbey URL https://www1.racgp.org.au/newsgp/clinical/study-questions-paxlovid-s-covid-19-usefulness?utm_source=racgpnewsgpnewsletter&utm_campaign=newsgpedm&utm_medium=email Persons Mark Morgan